Methodology and software to detect viral integration site hot-spots by Presson, Angela P et al.
Methodology and software to detect viral
integration site hot-spots
Presson et al.
Presson et al. BMC Bioinformatics 2011, 12:367
http://www.biomedcentral.com/1471-2105/12/367 (14 September 2011)RESEARCH ARTICLE Open Access
Methodology and software to detect viral
integration site hot-spots
Angela P Presson
1,2,5*, Namshin Kim
3, Yan Xiaofei
4, Irvin SY Chen
2,5,6 and Sanggu Kim
2,5
Abstract
Background: Modern gene therapy methods have limited control over where a therapeutic viral vector inserts
into the host genome. Vector integration can activate local gene expression, which can cause cancer if the vector
inserts near an oncogene. Viral integration hot-spots or ‘common insertion sites’ (CIS) are scrutinized to evaluate
and predict patient safety. CIS are typically defined by a minimum density of insertions (such as 2-4 within a 30-
100 kb region), which unfortunately depends on the total number of observed VIS. This is problematic for
comparing hot-spot distributions across data sets and patients, where the VIS numbers may vary.
Results: We develop two new methods for defining hot-spots that are relatively independent of data set size. Both
methods operate on distributions of VIS across consecutive 1 Mb ‘bins’ of the genome. The first method ‘z-
threshold’ tallies the number of VIS per bin, converts these counts to z-scores, and applies a threshold to define
high density bins. The second method ‘BCP’ applies a Bayesian change-point model to the z-scores to define hot-
spots. The novel hot-spot methods are compared with a conventional CIS method using simulated data sets and
data sets from five published human studies, including the X-linked ALD (adrenoleukodystrophy), CGD (chronic
granulomatous disease) and SCID-X1 (X-linked severe combined immunodeficiency) trials. The BCP analysis of the
human X-linked ALD data for two patients separately (774 and 1627 VIS) and combined (2401 VIS) resulted in 5-6
hot-spots covering 0.17-0.251% of the genome and containing 5.56-7.74% of the total VIS. In comparison, the CIS
analysis resulted in 12-110 hot-spots covering 0.018-0.246% of the genome and containing 5.81-22.7% of the VIS,
corresponding to a greater number of hot-spots as the data set size increased. Our hot-spot methods enable one
to evaluate the extent of VIS clustering, and formally compare data sets in terms of hot-spot overlap. Finally, we
show that the BCP hot-spots from the repopulating samples coincide with greater gene and CpG island density
than the median genome density.
Conclusions: The z-threshold and BCP methods are useful for comparing hot-spot patterns across data sets of
disparate sizes. The methodology and software provided here should enable one to study hot-spot conservation
across a variety of VIS data sets and evaluate vector safety for gene therapy trials.
Background
Gene therapy holds promise for curing HIV, cancer and
blood disorders by targeting and altering expression of
disease related genes [1-3]. Successful gene therapy relies
on the safe and efficient introduction of therapeutic
genetic material into the host genome by a modified
virus, such as lentivirus (LV) or murine leukemia virus
(MLV). Diseases that have been corrected by gene ther-
apy include X-linked severe combined immunodeficiency
(X-linked SCID), adenosine deaminase severe combined
immunodeficiency (ALD), and X-linked chronic granulo-
matous disease (CGD) [4-9]. However, the successes of
gene therapy have been somewhat offset by the accompa-
nying risk of ‘insertional mutagenesis’, or activation of
local gene expression near the integration site. In the X-
linked SCID studies, which employed MLV vectors, 25%
of patients developed T-cell lymphoproliferative syn-
drome within five years post-transplant due to vector
insertion near LMO2, BMI1a n dCCND2p r o t o - o n c o -
genes [8,10-12]. While no cancer cases have yet been
reported from LV studies, both LV and MLV vector
types exhibit preferential integration or integration ‘hot-
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DNA features located within or near vector integration
site (VIS) hot-spots to gain insight into the mechanism of
vector integration and predict potential long-term toxi-
city of gene therapy vectors [13-16].
The non-random nature of viral integration and the
potential for integration events to cause toxicity and
cancer have long been realized [17,18]. However, a for-
mal VIS hot-spot definition was not described until the
turn of the century when Suzuki et al. (2002) developed
a definition for retroviral integration in cancer cells to
discover potential cancer-related genes [19]. The authors
referred to a hot-spot as a Common Insertion Site (CIS)
and defined them as ≥4i n t e g r a t i o n sw i t h i na1 0 0k b
region, 3 integrations within 50 kb or 2 within 30 kb.
Similar definitions were adopted by others, such as 3
VIS within 100 kb [15] and 4 within 104 kb [20]. As in
these examples, it has been useful to tailor the hot-spot
definition to the data set under examination. This is
most commonly done using computer simulations or
mathematical analysis to select a CIS definition relative
to the current data set [19,21-23]. Wu et al. (2006) sug-
gested that unselected or acute infection VIS data
should be used as a reference or control data set for
defining hot-spots in the corresponding post transplant
data [21]. The authors reasoned that natural vector-spe-
cific biases exist, and for gene therapy applications it is
most interesting to see how the post-transplant VIS pre-
ferences compare to this reference (rather than for
example, randomly selected genomic locations). Thus a
suitable threshold for defining hot-spots in post-trans-
duced cells should detect few to no hot-spots in the
acute infection data.
More recently, Biffi et al. (2011) proposed a validation
step following traditional CIS analysis that confirms CIS
significance by comparing integration frequencies
among gene transcription units within the CIS interval
and its flanking genes [23]. This biologically motivated
approach is based on the concept that significant CIS
should identify genes with high integration frequencies,
as this could reveal potential for insertional mutagenesis.
While effective CIS definitions have been developed
for single data set analysis, it is less obvious how to con-
sistently define hot-spots across multiple data sets of
varying size. For example, a data set with 4000 VIS is
more likely to contain 4 VIS within 100 kb just by
chance than a data set with 400 VIS. While one can tai-
lor the CIS definition to data set size, to our knowledge
the utility of this approach has not been fully explored.
Furthermore, the CIS definition has been developed for
MLV data sets, where clustering tends to occur on the
kilobase scale. In an accompanying publication we
describe LV clustering in rhesus macaque, where some
hot-spots appear to span several megabases [23,24].
With these concepts in mind, we developed two new
hot-spot definitions based on z-transformed VIS densi-
ties. The first method ‘z-threshold’ simply applies a
threshold to z-transformed VIS densities. The second
method applies a bayesian change-point analysis ‘BCP’
to z-transformed VIS densities. BCP models have been
applied to other DNA sequence problems including the
detection of recombination events and DNA copy num-
ber variations [25-29]. Using simulated and real data
sets we show that the z-threshold and BCP methods
improve over a conventional CIS method by defining
hot-spots relatively independent of data set size. The
accompanying software implements these definitions
and provides graphical tools for visualizing VIS patterns
and hot-spots across data sets on the genome and chro-
mosome scales.
Results and Discussion
The fundamental tenets of our hot-spot definitions
include 1) hot-spot identification that is relatively inde-
pendent of data set size, 2) identification of few to no
hot-spots in the corresponding acute infection or pre-
transplant data, and 3) hot-spot identification and visua-
lization on both the kilobase and megabase scales. We
develop two novel methods: z-threshold and BCP, and
compare them with a conventional CIS definition: ≥3
VIS within 50 kb and ≥4 VIS within 100 kb (Figure 1A).
The z-threshold and BCP methods are useful for study-
ing hot-spot conservation across VIS data sets of varying
size, for example data collected on multiple subjects,
time-points or cell types. We also describe numerical
summary measures that indicate the extent of VIS clus-
tering, and a statistical test for comparing hot-spot con-
servation across data sets. Methods are illustrated on
real data from the X-linked ALD, CGD and X-linked
SCID studies [6-9,20] and simulated data derived from
the X-linked ALD study (Additional File 1).
The z-threshold and BCP methods rely on first parti-
tioning the genome or chromosomes into non-overlap-
ping 1 Mb bins. The megabase unit was chosen because
it worked well for defining hot-spots in our LV data
sets, however other units are certainly possible and may
be desirable for other vector types. The number of VIS
per bin gives a simple VIS density distribution, and
imposing a threshold to define high-count bins as hot-
spot regions would be similar to the CIS method. An
obvious extension then for comparing hot-spots among
data sets with differing VIS numbers, would be to divide
the bin counts by the total number of VIS in the data
set, and apply a threshold to these bin rates. (Note that
rather than defining hot-spots in 1 Mb units, we select
the closest VIS to each boundary, see Figure 1B). This
‘rate-threshold’ approach more uniformly defines hot-
spots across data sets of varying size than the CIS
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Page 2 of 12method (Figure 2A-B), but it is still affected by data set
size (Spearman p-value = 0.001). The threshold for
defining the Figure 2B hot-spots corresponded to the
99.92 percentile of the X-linked ALD acute infection
data set rates, 0.006. In the following section we show
that applying a z-score transformation to the bin counts
improves the uniformity of hot-spot results across data
sets of varying size.
Z-threshold hot-spot definition
The z-threshold definition also operates on non-overlap-
ping 1 Mb bins, but in this case the bin counts are stan-
dardized by both the overall mean and variance of a
data set’s bin count distribution. For bin i,t h ez - s c o r e
Xi is given by: [Ci - C]/[SE(C)], where Ci is the number
of VIS in bin i and C denotes the vector of all n mega-
base bin counts in the genome C1, C2, ..., Cn,w h e r e
chromosomes were artificially ‘strung together’ to form
one continuous genomic sequence. We then impose a
threshold of 422, corresponding to the 99.92 percentile
of the X-linked ALD acute infection data set z-scores,
and define all bins that exceed the threshold as ‘hot-
bins’. These hot-bin regions can then be further refined
by selecting the closest VIS to the bin boundaries (Fig-
ure 1B). We refer to these refined hot-bin regions as
hot-spots. While hot-spots are the main focus of this
paper, hot-bins are a useful approximation that can be
used in statistical analyses of hot-spot conservation.
Results for evaluating the percentage of VIS in hot-spots
across simulated data sets of increasing size show that
the z-threshold method is relatively invariant to data set
size (Figure 2C, Spearman p-value = 0.140).
BCP hot-spot definition
The concept of defining highly clustered VIS regions in
the genome can also be viewed as a change-point pro-
blem. In this framework change-points are genomic
locations that delineate between consecutive regions of
high and low VIS concentration. We implemented the
change-point model using the bcp package in R
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Figure 1 Definition of CIS, BCP and z-threshold hot-spot methods. (A) The CIS hot-spot definition implemented here is based on a
commonly used density metric [19,21]. (B) Our ‘z-threshold’ and ‘BCP’ hot-spot definitions operate on a partition of the genome into 1 Mb bins.
The number of VIS per megabase bin is tallied and then converted to a z-score by subtracting the mean and dividing by the standard error,
calculated across all bins. Bins with high z-scores are called ‘hot-bins’. Hot-spots are defined by grouping consecutive hot-bins and setting each
external boundary to the closest VIS.
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Page 3 of 12[26,30,31], operating on the z-scores of the megabase
bins described in the previous section. Again we ana-
lyzed the complete genome to allow detection of more
hot-spots on chromosomes that had a high VIS density
relative to other chromosomes. We ran the bcp function
with the default values except that we increased the
number of iterations from 500 to 10000 to improve con-
vergence (Additional File 2). We defined hot-bins by
applying the same threshold to the posterior means.
Similar to the z-threshold method the hot-spots are
relatively uniform across the simulated data sets (Figure
2D, Spearman p-value = 0.099), however both methods
give more consistent results for data sets with ≥ 300
VIS.
Details of the Bayesian change-point model
We applied a Bayesian change-point analysis to the bin
z-scores using a Gaussian model, which determined the
posterior probability of a change in z-scores at each bin
as well as the posterior means of the bins [32]. Briefly,
we define the z-score of bin i as Xi,f o ri = 1, ..., n
where Xi ~ N(μi, s
2); μ =( μ1, μ2,. . . ,μn); and define an
unknown partition of the n bins into b blocks as B =
(B1, B2,. . . ,Bb)w h e r eBi = 0, 1 such that ‘1’ indicates a
change-point. Define μij as the average z-score of the (i
+1 ,j)b l o c k ,s ot h a tXij ∼ N(μ0,σ2
0/(j − i)).T h el i k e l i -
hood of the data is given by
L(X|B,μ0,w) ∝
wb/2
[WSS + BSSw + wn(μ0 − X)
2
]
n/2
where w is the ratio of the error variance to the total
variance, and WSS and BSS are the within and between
block sum of squares, respectively [31,32]. On each
MCMC iteration, a change-point status Bi is sampled
for each position i according to probability Pr(Bi =1 | X,
Bj, j ≠ i)/Pr(Bi =0 | X, Bj, j ≠ i). After N iterations, the
set of partitions B1, B2,. . . ,BN were averaged to obtain
the posterior probabilities P1, P2, ..., Pn -1of a change-
point at each bin. We defined high density or hot-bins
by applying a threshold to the posterior bin means μ1,
μ2, ..., μn. We also used the average of the change-point
probabilities P to evaluate the extent of clustering in a
data set.
Results for human ALD, X-linked SCID, and CGD data
analysis
We analyzed seven LV and MLV data sets from five dif-
ferent human VIS studies (Table 1). Figure 3 gives an
overview of the relative VIS clustering in these data sets
using one minus the average of the change-point prob-
abilities 1 − P, and the maximum z-score divided by the
number of VIS, 100 · max(X)/
n
i=1 Ci.T h eC G Ds t u d y
data exhibits the highest degree of clustering according
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Figure 2 Comparison of % VIS in hot-spots for CIS, rate-threshold, z-threshold and BCP analyses for data sets with 200-2000 VIS.
Boxplots indicate distributions of % VIS in hot-spots for 12 simulated data sets per data set size for the CIS, rate-threshold, z-threshold and BCP
methods. Data set sizes are in increments of 100 for smaller data sets (200-600 VIS) to view performance when less data is available, and in
increments of 200 otherwise. The CIS method (A) shows an increasing percentage of VIS in hot-spots with increasing data set size across all data
set sizes. The z-threshold (C) and BCP (D) methods give the most consistent % VIS in hot-spots across data set sizes, with both methods giving
most consistent results for data sets with ≥300 VIS.
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Page 4 of 12to both measures, and the MLV acute infection data
exhibits the least clustering according to the maximum
z-score method.
For both the simulated and real data sets analyzed
here, as well as the real data sets analyzed in our accom-
panying publication [24], the BCP and z-threshold hot-
spot results were similar with a few exceptions. The
BCP method detected fewer hot-spots in the acute
infection data sets. For example, the BCP method
detected no hot-spots in the H-MLV-acute data, while
two hot-spots were detected by the z-threshold method
for this data set. In some cases, the BCP method can
accentuate signals that are both strong and sustained by
picking up lower signal bins adjacent to the strong sig-
nal (Additional File 3). It can also miss short signals
that are near the cut-off threshold. In the highly clus-
tered CGD data set the BCP method was unable to
detect a short but strong signal on chromosome 3.
While the BCP method is designed to detect short but
strong signals and weak but sustained signals [32], in
practice it can miss signals in sparse data sets or data
sets with only a few strong but short signals. As a result,
Table 1 Descriptions of human lentivirus (LV) and murine leukemia virus (MLV) vector integration site (VIS) data sets.
Data set Name Study # Type # VIS Time points Cell Type
H-LV-XALD X-Linked ALD [8] 2 LV 2401 6-24 m CD:34,15,3,14,16,19,56, LM
H-LV-Patient1 X-Linked ALD [8] 1 LV 1627 6-24 m CD:34,15,3,14,16,19,56, LM
H-LV-Patient2 X-Linked ALD [8] 1 LV 774 6-20 m CD:34,15,3,14,16,19
H-LV-acute X-Linked ALD [8] pre LV 922 – CD34
H-MLV-XCGD CGD [9] 2 MLV 384 1-45 m CD:3,14,15,19; PB, BM, G
H-MLV-XSCID SCIDX1 [6,7] 14 MLV 864 4-41 m CD:3,13,14,19; PBL, PBMC
– SCIDX1 [6] 5 MLV 303 9-30 m CD:3, 13
– SCIDX1 [7] 9 MLV 561 4-41 m CD:3,14,19; PBL, PBMC
H-MLV-acute GFP [20] pre MLV 1398 1-12 days PT CD34
The seven data sets analyzed here originated from five LV and MLV studies. Column one indicates the data set name given in this paper, and the ‘Study’ column
indicates the parent study where X-linked ALD (adrenoleukodystrophy), CGD (chronic granulomatous disease) and SCIDX1 (X-linked severe combined
immunodeficiency) refer to human clinical trials, and GFP (green fluorescent protein) indicates a control vector study. The H-MLV-XSCID data set was derived
from two different studies [6,7] as indicated. The ‘#’ column indicates the number of subjects analyzed; ‘Type’ refers to vector type, LV or MLV; ‘# VIS’ indicates
the number of unique vector integration sites; ‘Time points’ indicates the number of time points from which samples were obtained; and ‘Cell Type’ indicates the
cells from which VIS were derived. LAM sequencing was used exclusively in all studies except the GFP study which used an LM/LAM combination.
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Figure 3 Comparison of VIS clustering among data sets. We developed two methods to describe the extent of VIS clustering. The first
method ‘maximum %’ is simply the maximum bin’s z-score divided by the total number of VIS in the data set,100 · max(X)/
n
i=1 Ci. Data
sets with a maximum % > 8 indicate a high degree of clustering. The second method ‘BCP posterior probability’ is calculated after running the
Bayesian change-point analysis, and is simply one minus the average of the posterior probabilities of a change point occurring at each bin,
1 − P. BCP posterior probabilities > 0.98 indicate a high degree of clustering. Both methods indicate that the CGD data exhibits a high degree
of clustering with a maximum % and BCP posterior probabilities of 11.98 and 0.999, respectively, in comparison to the other data sets which
ranged from 0.5-1.48 and 0.9356-0.9361, respectively.
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Page 5 of 12we have set 300 as the lower bound for data set size
using the BCP approach, and smaller data sets with
(100,300] VIS are analyzed by the z-threshold method.
Furthermore, highly clustered data sets (1 − P > 0.98)
are analyzed with the z-threshold method. These rules
govern the BCP hot-spot results presented in the follow-
ing sections, where only the CGD data set qualified as
highly clustered and all data sets had VIS numbers
greater than 300. We recommend that users run both
the BCP and z-threshold analyses. Differences could be
resolved by either choosing the preferred method based
on a visual assessment or taking the union of their
results. Due to the similarities between the BCP and z-
threshold hot-spot results, for simplicity the following
sections compare only the BCP results with the CIS
method.
BCP hot-spot results
Hot-spot results for the seven data sets are provided in
Table 2. Consistent with the cluster results from Figure
3, the CGD data set (H-MLV-XCGD) has the highest
median hot-spot density according to both the BCP and
CIS methods. The percentage of VIS in BCP hot-spots
was similar for the full ALD data set and in patients 1
and 2 considered separately, at 6.21%, 7.74% and 5.56%,
respectively. In comparison, the CIS analysis resulted in
22.7%, 15.86% and 5.81%, respectively, where the
decreasing percentage of VIS corresponded to decreas-
ing data set size (2401, 1627 and 774 VIS). Figure 4A
shows that major hot-spots in the ALD data sets (H-
LV-XALD, H-LV-Patient1 and H-LV-Patient2) occurred
on chromosomes 6, 11, 12 and 17, and Figures 4B-C
show chromosome views of the major hot-spot on chro-
mosome 6. An analogous genome-scale view for the CIS
hot-spots can be found in Additional File 4.
While most of the biological discussion of these hot-
spots has been relegated to our accompanying publica-
tion [24], Figure 5 shows results for commonly studied
genomic features including densities of all RefSeq genes,
cancer genes, CpG islands and simple repeats. RefSeq
gene (5A) and CpG island (5C) densities are higher in
the H-LV-XALD, H-LV-Patient1 and H-LV-Patient2
data sets than the genome average. The percentage of
genes implicated in cancer is highest in the CGD data
set but with only one cancer-related gene EV I1o u to f
seven RefSeq genes, it did not achieve significance.
Overlap of interquartile ranges for all genomic features
indicates hot-spot similarities for the ALD study and
patients 1 and 2.
BCP hot-spot conservation
The BCP and z-threshold hot-spot definitions also
enable us to numerically compare hot-spot conservation
between data sets. This can be done using a Fisher’s
exact test of hot-bin overlap between a pair of data sets.
Previously we described hot-spot overlap for patients 1
and 2 in comparison to the full X-linked ALD data set
(Table 3). If we wish to formally test for hot-spot con-
servation between the patient 1 data set and the X-
linked ALD data set, it is useful to use hot-bins rather
than hot-spots to control for hot-spot size. Patient 1 has
8 hot-bins and the full X-linked ALD data set has 7
hot-bins (reflecting the decomposition of the Chr 11
hot-spot into three 1 Mb bins), and 6 hot-bins overlap
between these data sets. The overlap between these data
sets can be summarized in a 2 × 2 table as follows:
H - LV - XALD + H - LV - XALD -
H-L V-P a t i e n t 1+ 6 2
H-L V -P atient1- 1 3082
where the ‘+’ d e n o t e sh o t - b i n sa n d‘-’ denotes non-
hot-bins, and the total number of megabase bins in the
human genome is 3091. The Fisher’s exact test p-value
for this table is < 2.2 × 10
-16. Patient 2 with 6 hot-bins
total and two overlapping with the H-LV-XALD data
set is also significant, p-value = 6.6 × 10
-5.I n
Table 2 Hot-spot summaries for human LV and MLV data sets using the BCP and CIS hot-spot definitions.
# Hot-Spots % VIS in HS % Coverage Size (Mb) % Density*
Data Set Total VIS BCP CIS BCP CIS BCP CIS BCP CIS BCP CIS
H-LV-acute 922 3 11 2.93 5.1 0.101 0.02 1.045 0.055 0.93 8.98
H-LV-XALD 2401 5 110 6.21 22.7 0.213 0.246 1.316 0.069 0.86 2.95
H-LV-Patient1 1627 6 56 7.74 15.86 0.251 0.119 1.291 0.066 0.96 4.69
H-LV-Patient2 774 6 12 5.56 5.81 0.17 0.018 0.874 0.047 1.04 10.07
H-MLV-acute 1398 0 15 0 3.93 0 0.017 0 0.035 0 7.29
H-MLV-XCGD 384 2 3 16.93 16.67 0.037 0.009 0.564 0.09 165.32 228.5
H-MLV-SCIDX1 864 7 22 5.9 11 0.045 0.029 0.197 0.041 4.02 13.82
Relative to the CIS method, the BCP hot-spot definition identified fewer hot-spots containing a smaller percentage of VIS for all data sets. It also gave the most
consistent results across the full X-linked ALD data set, and patients 1 and 2. The % VIS in hot-spots (HS) ranged from 5.56% to 7.74% for the BCP method and
5.81% to 22.7% using the CIS hot-spot definition. The CIS definition found similar hot-spot numbers and % VIS in hot-spots for the acute infection data set and
post-transplant data for patient 2. Both the BCP and CIS methods indicate differences in hot-spot patterns between the LV and MLV data sets. In particular, the
CGD study data had very few hot-spots with high VIS densities. % Density was calculated as (Median # VIS per HS/# Total VIS)*100/Mb. Data set names are as in
Table 1.
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Page 6 of 12comparison, the p-value for comparing the H-LV-XALD
data set to the acute infection data (with one overlap-
ping hot-bin) is 0.007. In the case where no hot-spots
are found in the acute infection data, it might be useful
to apply a conservative threshold such as 0.007 for eval-
uating significance.
Software for hot-spot analysis
The accompanying R software and tutorial in Additional
File 5 enable the user to implement all three hot-spot
definitions CIS, BCP and z-threshold for both human
and rhesus macaque VIS data sets. The main code file
“main.r” is broken into seven major sections listed
b e l o w ,w h e r eo n l yt h ef i r s tt w oa r en e e d e dt od e f i n e
hot-spots and the remaining code supports additional
analyses described in this paper. Run times for each step
are provided in parentheses based on an analysis for
seven real human data sets with 2401, 1627, 1398, 922,
864, 774, and 384 VIS (or 1196 VIS on average per data
set) clocked on a windows machine with an Intel Core
i5 2.53 GHz processor and 4 GB of RAM.
1. Install R packages, read in data files, set run para-
meters. (17.61 sec)
2. Define hot-bins and hot-spots. (12.87 sec for z-
threshold, 17.36 min for BCP)
A. FullgenomeBCPhotͲspotanalysis
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Figure 4 Graphical displays of BCP hot-spot results from the SCIDX1, CGD, and X-linked ALD trials. Our hot-spot software produces three
types of plots for viewing hot-spot results, (A) a stripchart that displays the full genome for all data sets analyzed, (B) a stripchart that displays
results for all data sets, one chromosome at a time; and (C) a barplot that displays results for one data set and chromosome at a time. In all plot
types the grey color corresponds to VIS (A, B) or VIS bins (C) that were not defined as hot-spots. In all three plot types the x-axis corresponds to
location in megabase units. In plot type C, the y-axis corresponds to bin rate (# VIS per bin/total # VIS) rather than z-score for visual clarity since
z-scores can be negative. Color definitions were assigned to each data set independently based on quantiles of its non-zero z-score distribution
(ie, the distribution of bin z-scores among bins with non-negative scores). VIS that were located in hot-spot regions corresponding to bins with
z-score distributions ≤ 85th percentile are colored light blue, > 85 and ≤ 95 are dark blue, > 95 and ≤ 97.5 are purple, > 97.5 and ≤99 are pink
and > 99 are colored red. The plots illustrate hot-spots on chromosomes 6, 11, 12 and 17 in the X-linked ALD data set, and the presence of the
chromosome 6 hot-spot in both patients analyzed separately. The MLV data sets exhibit unique VIS patterns that differ from each other as well
as the LV data.
Presson et al. BMC Bioinformatics 2011, 12:367
http://www.biomedcentral.com/1471-2105/12/367
Page 7 of 123. Run conventional CIS analysis. (9.97 sec)
4. Get genes overlapping or located within hot-spots.
(4.51 min no CIS, 9.28 min with CIS)
5. Compare hot-bins between two groups. (3.10 sec)
6. Statistics for hot-spot gene enrichment. (6.46 min)
7. Merge hot-spot results from two different genome
partitions. (1.40 sec)
Steps 2 (for the BCP method only), 4 and 6 are the
most time-consuming ranging from 4.51-17.36 minutes
for this 7 data set analysis. The BCP method takes con-
siderably longer than the z-threshold approach because
the BCP analysis requires 10,000 MCMC iterations
(about 2.2 minutes) per data set. In comparison the z-
threshold method simply applies a threshold to the bin
scores, which happens instantaneously (the additional
time for both the BCP and z-threshold methods is spent
retrieving hot-spot statistics and plots).
The “main.r” and the “README.txt” files provide
guidelines for how to change parameters that govern the
CIS, BCP and z-threshold hot-spot methods, such as
how to change the threshold for defining hot-bins for
the BCP and z-threshold methods (step 1). The default
threshold 422, corresponds to the 99.92 percentile of
the X-linked ALD acute infection data set z-scores, and
was determined using both the data analyzed here and
in our accompanying publication [24]. We used this
same threshold for the MLV data to compare the LV
and MLV vector types. While it works well for a variety
of data sets, this threshold can easily be adjusted, for
example to the 99.92 percentile (or other percentiles) of
the acute infection data in other studies. We provide a
simple function getThreshold to tailor this threshold to
other VIS studies.
Step 2 executes the detection of hot-bins and hot-
spots according to the methods outlined in step 1. Step
3 enables the user to run a conventional CIS analysis
using either the default definition provided (≥ 3V I S
within 50 kb and ≥ 4V I Sw i t h i n1 0 0k b )o ra l t e r n a t i v e
definitions as desired. Step 4 finds genes that overlap or
are located within hot-spots and/or contain at least one
VIS, and step 6 evaluates the significance of hot-spot
Table 3 BCP hot-spots for the LV acute infection, full X-linked ALD, and patient 1 and 2 data sets.
Data set # VIS Chr Location (Mb) # VIS (%) Size (Mb) % Density
H-LV-acute 922 Chr 11 65.020-65.721 12 (1.30%) 0.7 1.86
H-LV-acute 922 Chr 16 0.425-1.929 7 (0.76%) 1.5 0.51
H-LV-acute 922 Chr 17 77.185-78.117 8 (0.87%) 0.93 0.93
Median - - - 8 (0.87%) 0.93 0.93
H-LV-XALD 2401 Chr 6 31.967-33.000 35 (1.46%) 1.03 1.41
H-LV-XALD 2401 Chr 11 64.005-66.969 61 (2.54%) 2.96 0.86
H-LV-XALD 2401 Chr 12 6.085-6.993 16 (0.67%) 0.91 0.73
H-LV-XALD 2401 Chr 17 2.000-2.522 17 (0.71%) 0.52 1.36
H-LV-XALD 2401 Chr 17 73.098-74.252 20 (0.83%) 1.15 0.72
Median - - - 20 (0.83%) 1.03 0.86
H-Patient1 1627 Chr 6 31.967-33.000 25 (1.54%) 1.03 1.49
H-Patient1 1627 Chr 11 64.019-66.969 47 (2.89%) 2.95 0.98
H-Patient1 1627 Chr 12 6.085-6.993 14 (0.86%) 0.91 0.95
H-Patient1 1627 Chr 17 73.098-74.252 15 (0.92%) 1.15 0.8
H-Patient1 1627 Chr 17 77.093-77.863 13 (0.8%) 0.77 1.04
H-Patient1 1627 Chr 19 53.882-54.813 12 (0.74%) 0.93 0.79
Median - - - 14.5 (0.89%) 0.98 0.965
H-Patient2 774 Chr 1 2.038-2.954 6 (0.78%) 0.92 0.85
H-Patient2 774 Chr 3 47.057-47.926 6 (0.78%) 0.87 0.89
H-Patient2 774 Chr 6 31.867-32.976 11 (1.42%) 1.11 1.28
H-Patient2 774 Chr 16 0.592-1.838 7 (0.9%) 1.25 0.73
H-Patient2 774 Chr 17 2.000-2.452 7 (0.9%) 0.45 2
H-Patient2 774 Chr 17 76.215-76.864 6 (0.78%) 0.65 1.19
Median - - - 6.5 (0.84%) 0.89 1.04
Five hot-spots were identified by the BCP method for the post infection X-linked ALD data set, ranging in size from 0.52-2.96 Mb with a median density of 0.86%
total VIS/Mb. When the ALD study patients were analyzed separately, six hot-spots were observed for each patient with similar sizes and densities. Patient 1 had
four hot-spots that overlapped with the full X-linked ALD data set on chromosomes (Chr) 6, 11, 12 and 17; as well as two additional hot-spots on Chr 17 and 19.
Patient 2 had two hot-spots that overlapped with the full data set on Chr 6 and 17, as well as four additional hot-spots on Chr 1, 3, 16 and 17. In comparison,
the acute infection data with three hot-spots had one overlap with the full ALD data set on Chr 11, a unique hot-spot on Chr 16, and a hot-spot on Chr 17 that
overlapped with Patient 1’s Chr 17 hot-spot. % Density was calculated as (# VIS per HS/# Total VIS)*100/Mb. Data set names are as in Table 1.
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Page 8 of 12gene enrichment relative to the genome. Step 5 con-
ducts the analysis described in the “BCP hot-spot con-
servation” section of this paper, where hot-bins are
compared between two groups using a Fisher’s exact
test. Step 7 enables the user to merge hot-spot results
from two different genome partitions, the original parti-
tion (bin1 = 0-1 Mb, bin2 = 1-2 Mb,..., bin3091 = 3090-
3091 Mb) and an alternative partition that is shifted by
a specified amount, such as 0.5 Mb from the original
partition (bin1 = 0-0.5 Mb, bin2 = 0.5-1.5 Mb,...,
bin3115 = 3090.5-3091.0 Mb). The shift amount [0-1
Mb) is governed by shiftBins in step 1, where the origi-
nal partition is obtained with no shift shiftBins =0 .
We allow the user to run alternative partitions of the
genome because an anonymous reviewer pointed out
that hot-spot results may depend upon the partition.
Indeed, when we run the BCP hot-spot analysis with the
bins maximally shifted by 0.5 Mb for the H-LV-XALD,
H-LV-Patient1 and H-LV-Patient2 data sets there are
differences in hot-spot results. These three data sets had
5, 6 and 6 hot-spots for the original bin positions and 6,
5 and 7 hot-spots, respectively for the +0.5 Mb bin posi-
tions. There were 4, 3 and 3 matches between the
resulting hot-spots from these two partitions for each
data set, respectively, or 50-80% correspondence (#
matches/# original hot-spots). The merged results
yielded 7, 8 and 10 hot-spots, where the overlap
between the H-LV-XALD and H-LV-Patient2 hot-spots
increased by over 30% from 2/5 to 5/7 (# overlaps/#
hot-spots in H-LV-XALD). The overlap between the H-
LV-XALD and H-LV-Patient1 hot-spots were similar at
4/5 for the original partition and 5/7 after merging the
two partitions (9% decrease). In comparison, the overlap
between H-LV-acute and H-LV-XALD also changed lit-
tle with 1/5 overlaps for the original partition and 1/7
after merging (6% decrease). If we consider four genome
partitions (shiftBins = 0, 0.25, 0.5 and 0.75) the merged
results yield 8, 10 and 11 hot-spots, where the H-LV-
XALD and patient data sets see an increase of 16.5% to
7/8 hot-spot overlaps, and the overlap between H-LV-
XALD and H-LV-acute increases by 11% to 2/8. Consid-
ering additional genome partitions increases the hot-
spot yield and improves correspondence between data
sets that have similar VIS patterns. As a result, we allow
the user to run multiple genome partitions as desired
(using the shiftBins parameter in step 1) and merge the
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Figure 5 Genome features of BCP hot-spots in the SCIDX1, CGD, and X-linked ALD trials. Plots (A), (C), and (D) show the median feature
density per Mb and the interquartile range of BCP hot-spot regions in comparison to the genome median. In plot B the enrichment of cancer
genes was calculated relative to the RefSeq gene numbers in order to control for gene density differences. The LV data sets showed enrichment
of (A) RefSeq genes and (C) CpG islands relative to the genome median (indicated by an asterisk *). No other comparisons to the genome
median reached significance at the Bonferroni-corrected level. Overlap of interquartile ranges among the LV data sets shows that their BCP hot-
spots have similar genomic features.
Presson et al. BMC Bioinformatics 2011, 12:367
http://www.biomedcentral.com/1471-2105/12/367
Page 9 of 12results (step 7) to achieve a more comprehensive set of
hot-spots.
Conclusions
Lentiviral vectors exhibit strong preferences for specific
genomic regions that can encompass several megabases.
We describe two novel methods, BCP and z-threshold,
that can consistently define hot-spots on the kilobase
and megabase scales across data sets of varying size.
The BCP method identifies similar numbers of hot-
spots 5-6 containing similar percentages of VIS 5.56-
7.74% across individual patients and the combined data
from the X-linked ALD clinical trial, which varied sev-
eral fold in size. In comparison, a conventional CIS
method identified 12-110 hot-spots containing VIS per-
centages 5.81-22.7% across the same data sets.
The proposed methods are useful for identifying VIS
hot-spots on the megabase scale and comparing gen-
ome-wide VIS patterns among data sets of varying size.
VIS hot-spot analysis can provide insight into mechan-
isms of vector integration that will help evaluate the
safety of potential gene therapy vectors. The accompa-
nying software and R tutorial will facilitate application
of these methods to additional VIS data sets.
Methods
Common Insertion Site (CIS) hot-spot definition
While the exact CIS definition varies by study, hot-spots
are defined using density thresholds such as 2-4 VIS
within a 30-100 kb region [19,21]. Here we adopt the
following CIS hot-spot definition: ≥ 3i n5 0k ba n d≥ 4
in 100 kb (Figure 1A). To implement the CIS method
for an Xkb window and minimum VIS count Y,s t a r ta t
the first position on chromosome and count the number
of VIS within the Xkb window. If the number is ≥ Y ,
the region is considered a hot-spot. Shift the window 1
bp and repeat. Continue until all possible Xkb windows
have been considered for all chromosomes.
Simulated data analysis
Simulated data sets were constructed by sampling with-
out replacement (ie no VIS was sampled more than
once per test data set) from the full human X-linked
ALD data set [8], which consisted of 2401 total unique
VIS. Simulated data sets consisted of the following sizes:
200, 300, 400, 500, 600, 800, 1000, 1200, 1400, 1600,
1800 and 2000 VIS. Each data set size was sampled 10
times resulting in 120 total simulated data sets. Addi-
tional File 1 shows the ranges in numbers of VIS
observed per chromosome for the 400 and 1800 VIS
data sets in comparison to the actual percentage of VIS
per chromosome in the full X-linked ALD data set. The
simulated data is provided with the R software in Addi-
tional File 5. We tested for a relationship between the
percentage of VIS in hot-spots versus data set size by
calculating the median percentage of VIS in hot-spots
for each size, and performing a Spearman correlation
test with the number of VIS per data set.
Genome feature analysis of BCP hot-spots
RefSeq genes, CpG island and simple repeat data were
downloaded from the UCSC genome browser http://
hgdownload.cse.ucsc.edu/goldenPath/hg18/database/.
Megabase densities of these features were calculated for
each BCP hot-spot by dividing the number of features
in the hot-spot by the hot-spot size. Median hot-spot
densities and their interquartile ranges are plotted in
Figure 5. A Wilcoxon rank sum test with continuity cor-
rection was used to compare the median density of each
data set with the genome median. This resulted in a
total of 20 tests (5 data set comparisons × 4 genomic
features), so we use a Bonferroni-corrected level of
0.0025 to assess significance. Cancer gene data was
obtained from the National Cancer Institute http://
ncicb.nci.nih.gov/projects/cgdcp. The percentage of can-
cer genes was calculated for each data set by dividing
the number of cancer genes located in hot-spots by the
total number of RefSeq genes located in hot-spots, in
order to control for gene density differences.
Additional material
Additional file 1: Distribution of simulated VIS data sets (400 and
1800 VIS) by chromosome. The percentage of total VIS by
chromosome in the full human X-linked ALD data set is shown in red.
We sampled without replacement from the full human X-linked ALD
data set to create ten simulated data sets per size for 12 sizes, ranging
from 200 to 2000 VIS in intervals of 100 for 200-600 and intervals of 200
thereafter. The minimum and maximum percentages of VIS per
chromosome for the 400 and 1800 VIS data sets are shown in the figure
as blue and green bars, respectively.
Additional file 2: Convergence analysis of BCP method on full X-
linked ALD data set. Five start seeds were used to assess the
convergence of the BCP results for run lengths of 500, 1000, 5000 and
10000 iterations. For each run length we plot the range of BCP-estimated
z-scores (posterior means) for each bin versus the minimum z-score from
the 5 differently seeded runs. In each plot there are 3091 points
corresponding to the number of 1 Mb bins in the human data set. The
dashed line indicates the z-score threshold of 422, where bins with z-
scores to the right of this line were called hot-bins. The solid diagonal
line indicates the lower bound for a bin’s minimum z-score and range to
achieve before it would be considered a hot-bin. Even for the short 500
iteration runs there were no cases where a bin was inconsistently called
a hot-bin. However, the 500 and 1000 iteration runs (A-B) show that bins
with minimum z-scores < 100 could have z-score differences of 45-65 for
different start seeds. Z-score differences across start seeds becomes
much smaller for bins with larger z-scores even for short 500 iteration
runs. Among the 7 hot-bins corresponding to the 5 hot-spots reported
in Table 3, a run length of 5000 iterations achieved posterior z-score
estimates that had an SD of 0.007 or less. Based on these results we
recommend a minimum run length of 5000 iterations.
Additional file 3: Differences between the z-threshold and BCP
methods. A comparison of hot-spot results between the BCP and z-
threshold methods for the complete set of human X-linked ALD, X-linked
CGD and X-linked SCID data sets (described in Table 1) shows four
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Page 10 of 12differences. The BCP method did not find hot-spots in the MLV acute
infection data, whereas the z-threshold identified two (not shown). Also,
two hot-spots that had z-scores near the cut-off threshold in the X-linked
ALD patient 2 data at Chr 1 and Chr 3 were not found by the BCP
method. The BCP method can miss some of the more minor hot-spots
that the z-threshold method detects, but it detects fewer hot-spots in
the acute infection data. Furthermore, analyses of additional data sets in
our accompanying publication [24] have shown that in some cases the
BCP method detects greater hot-spot coverage for strong signals (see
rhesus macaque animal 2RC003 on Chr 14, below). Overall, these
methods perform similarly, and we suggest running both for major data
sets to check consistency of hot-spot results.
Additional file 4: CIS results for human data from SCIDX1, CGD, and
X-linked ALD trials. This plot is the CIS version of Figure 4A, showing
the CIS hot-spots (indicated in red) on a genome level for all LV and
MLV data sets. Grey indicates VIS that were not located in hot-spots.
Data set names are as in Table 1.
Additional file 5: R software and tutorial for running the CIS, z-
threshold and BCP hot-spot analyses. This file contains R code and
data sets to recreate the figures and table data presented in the paper.
There are also instructions on how to change parameters to analyze
other VIS data sets. See the ‘README.txt’ file for details.
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